Cargando…
Current trends of clinical trials involving CRISPR/Cas systems
The CRISPR/Cas9 system is a powerful genome editing tool that has made enormous impacts on next-generation molecular diagnostics and therapeutics, especially for genetic disorders that traditional therapies cannot cure. Currently, CRISPR-based gene editing is widely applied in basic, preclinical, an...
Autores principales: | Zhang, Songyang, Wang, Yidi, Mao, Dezhi, Wang, Yue, Zhang, Hong, Pan, Yihan, Wang, Yuezeng, Teng, Shuzhi, Huang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666174/ https://www.ncbi.nlm.nih.gov/pubmed/38020120 http://dx.doi.org/10.3389/fmed.2023.1292452 |
Ejemplares similares
-
Current trends in gene recovery mediated by the CRISPR-Cas system
por: Jang, Hyeon-Ki, et al.
Publicado: (2020) -
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
por: Yang, Yue, et al.
Publicado: (2021) -
Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13
por: Wang, Hao, et al.
Publicado: (2022) -
CRISPR/Cas9-mediated targeted chromosome elimination
por: Zuo, Erwei, et al.
Publicado: (2017) -
Current advances of CRISPR-Cas technology in cell therapy
por: Qiu, Hou-Yuan, et al.
Publicado: (2022)